This educational activity is designed for physicians, advanced-practice nurses, and other clinicians specializing in psychiatry, psychology, neurology, primary care, or pediatrics who care for individuals with ADHD.

1. Describe the neurobehavioral burden of emotional dysregulation and related comorbidities in ADHD (eg, anxiety, executive dysfunction), and examine the limitations of current treatments in addressing these challenging symptom domains 
2. Explain the role of serotonergic signaling in the regulation of emotion and cognition in ADHD, and describe how serotonin interacts with dopamine and norepinephrine pathways to influence treatment targets 
3. Evaluate novel pharmacologic targets involving serotonergic modulation as emerging strategies to address under-recognized and under-treated features of ADHD 
4. Apply individualized, developmentally-informed treatment strategies for patients with stimulant intolerance, comorbid symptoms, or residual impairment in clinical scenarios